VEGFA and neoplasm: For instance, Shen et al. [168] employed probes to deliver doxorubicin (DOX) along with vascular endothelial growth factor (VEGF)-targeted small hairpin RNA (shRNA) into tumor cells, demonstrating a pronounced synergistic antitumor effect.